tiprankstipranks
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Financial Statements

790 Followers

Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently $6.93M. The company's EPS TTM is $-0.2436; its P/E ratio is -0.23; Hepion Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -4.16M$ -19.35M$ -48.45M$ -45.49M$ -30.40M
EBITDA$ -3.73M$ -14.88M$ -49.26M$ -45.00M$ -32.63M
Net Income$ -8.28M$ -13.19M$ -48.93M$ -42.20M$ -32.72M
Balance Sheet
Cash & Short-Term Investments$ 1.83M$ 406.41K$ 14.79M$ 51.19M$ 91.35M
Total Assets$ 3.07M$ 1.61M$ 18.09M$ 60.24M$ 103.55M
Total Debt$ 54.07K$ 2.90M$ 209.02K$ 53.61K$ 316.99K
Net Debt$ -1.77M$ 2.49M$ -14.58M$ -51.14M$ -91.03M
Total Liabilities$ 402.40K$ 3.48M$ 10.81M$ 10.39M$ 10.56M
Stockholders' Equity$ 2.67M$ -1.86M$ 7.28M$ 49.86M$ 93.00M
Cash Flow
Free Cash Flow$ -3.27M$ -18.22M$ -40.90M$ -34.98M$ -31.35M
Operating Cash Flow$ -3.27M$ -18.22M$ -40.89M$ -34.96M$ -31.22M
Investing Cash Flow$ -132.12K$ -600.00K$ -14.30K$ -14.07K$ -130.41K
Financing Cash Flow$ 4.83M$ 4.35M$ 4.49M$ -5.14M$ 81.98M
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS